The aryl hydrocarbon receptor nuclear translocator (ARNT) modulates the antioxidant response in AML cells

Leukemia Research

Volumn 37, Issue 12, 2013, Pages 1750-1756

  Gu, Chunhong ^a   Gonzalez, Joelle ^a   Zhang, Tong ^b   Kamel Reid, Suzanne ^b   Wells, Richard A ^a  

^a Canada   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

ARNT; Chemoresistance; Hypoxia inducible factor; Oxidative stress; Reactive oxygen species

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CIGLITAZONE; COMPLEMENTARY DNA; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; GLUTATHIONE; PROTEIN; REACTIVE OXYGEN METABOLITE; SOD2 PROTEIN; SUPEROXIDE; TRANSCRIPTION FACTOR ARNTL; TRANSCRIPTION FACTOR NRF2; TROGLITAZONE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ARTICLE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; TREATMENT RESPONSE;

EID: 84888137620     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.10.010     Document Type: Article

References (41)

1. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., et al. The nuclear receptor superfamily: the second decade. Cell 1995, 83(6):835-839.
2. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willison T.M., Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995, 270(22):12953-12956.
3. Tsubouchi Y., Sano H., Kawahito Y., Mukai S., Yamada R., Kohno M., et al. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. Biochem Biophys Res Commun 2000, 270(2):400-405.
4. Elstner E., Muller C., Koshizuka K., Williamson E.A., Park D., Asou H., et al. Ligands for peroxisome proliferato-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci U S A 1998, 95(15):8806-8811.
5. Kitamura S., Miyazaki Y., Shinomua Y., Kondo S., Kanayama S., Matsuzawa Y. Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells. Jpn J Cancer Res 1999, 90(1):75-80.
6. Eibl G., Wente M.N., Reber H.A., Hines O.J. Peroxisome proliferator-activated receptor gamma induces pancreatic cancer cell apoptosis. Biochem Biophys Res Commun 2001, 287(2):522-529.
7. Tontonoz P., Singer S., Forman B.M., Sarraf P., Fletcher J.A., Fletcher C.D., et al. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc Natl Acad Sci U S A 1997, 94(1):237-241.
8. Hirase N., Yanase T., Mu Y., Muta K., Umemura T., Takayanagi R., et al. Thiazolidinedione suppresses the expression of erythroid phenotype in erythroleukemia cell line K562. Leuk Res 2000, 24(5):393-400.
9. Hiras N., Yanase T., Mu Y., Muta K., Umemura T., Takayanagi R., et al. Thiazolidinedione induces apoptosis and monocytic differentiation in the promyelocytic leukemia cell line HL60. Oncology 1999, 57(Suppl. 2):17-26.
10. Kamel-Reid S., Zhang T., Wells R.A. Expression of NPM-RARalpha fusion gene in hematopoietic cells confers sensitivity to troglitazone-induced apoptosis. Oncogene 2003, 22(4):6424-6435.
11. Perez-Ortiz J.M., Tranque P., Burgos M., et al. Glitazones differentially regulate primary astrocyte and glioma cell survival, involvement of reactive oxygen species and peroxisome proliferator-activated receptor-gamma. J Biol Chem 2004, 279(10):8976-8985.
12. Pandhare J., Cooper S.K., Phang J.M. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms. J Biol Chem 2006, 281(4):2044-2052.
13. Valko M., leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39(1):44-84.
14. Kumar B., Koul L., Khandrika L., Meacham R.B., Koul H.K. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 2008, 68(6):1777-1785.
15. Fried L., Arbiser J.L. The reactive oxygen-driven tumor: relevance to melanoma. Pigm Cell Melanoma Res 2008, 21(2):117-122.
16. Battisi V., Maders L.D., Bagatini M.D., et al. Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients. Clin Biochem 2008, 41(7-8):511-518.
17. Farquhar M.J., Bowen D.T. Oxidative stress and the myelodysplastic syndromes. Int J Hematol 2003, 77(4):342-350.
18. Sallmyr A., Fan J., Rassool F.V. Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair. Cancer Lett 2008, 270(1):1-9.
19. Jeanne M., Lallemand-Breitenbach V., Ferhi O., Koken M., Le Bras M., Duffort S., et al. PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3. Cancer Cell 2010, 18(1):88-98.
20. Mansat-De Mas V., Bezombes C., Quillet-Mary A., et al. Implication of radical oxygen species in ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicin. Mol Pharmacol 1999, 56:867-874.
21. Warner G.C., Reis P.P., Jurisica I., Sultan M., Arora S., Macmillan C., et al. Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis. Int J Cancer 2004, 110(6):857-868.
22. Laurent G., Jaffrezou J.P. Signalling pathways activated by daunorubicin. Blood 2001, 98(4):913-924.
23. Flemming R.A., Miller A.A., Stewart C.F. Etoposide: an update. Clin Pharm 1989, 8(4):274-293.
24. Kufe D.W., Griffin J.D., Spriggs D.R. Cellular and clinical pharmacology of low-dose ara-C. Semin Oncol 1995, 12(Suppl. 2):200-207.
25. Zhang B., Chen N., Chen H., Wang Z., Zheng Q. The critical role of redox homeostasis in shikonin-included HL60 cell differentiation via unique modulation of the Nrf2/ARE pathway. Oxid Med Cell Longev 2012, 16:7815.
26. Rushworth S.A., Bowles K.M., MacEwan D.J. High basal nuclear levels of Nrf2 in acute myeloid leukemia reduces sensitivity to proteasome inhibitors. Cancer Res 2011, 71(5):1999-2009.
27. Liu Q., Zhang H., Smeester L., Zou F., Kesic M., Jaspers I., et al. The Nrf2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel. MBC Med Genomics 2010, 3:37.
28. Fukai T., Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal 2011, 15(6):1583-1606.
29. Hassan H.M. Biosynthesis and regulation of superoxide dismutases. Free Radic Biol Med 1988, 5(5-6):377-385.
30. Motohashi H., Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 2004, 10(11):549-557.
31. Maltepe E., Schmidt J.V., Bsunoch D., Bradfield C.A., Simon M.C. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997, 386(6623):403-407.
32. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 1998, 12(2):149-162.
33. Ryan H.E., Lo J., Johnson R.S. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 1998, 17(11):3005-3015.
34. Fernandez-Salguero P., Pineau T., Hilbert D.M., McPhail T., Lee S.S., Kimura S., et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 1995, 268(5211):722-726.
35. McDonnell W.M., Chensue S.W., Askari F.K., Molseley R.H. Hepatic fibrosis in Ahr-/- mice. Science 1996, 271(5246):223-224.
36. Salomon-Nguyen F., Della-Valle V., Mauchauffe M., busson-Le Coniat M., Ghysdael J., Berger R., et al. The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion. Proc Natl Acad Sci U S A 2000, 97(12):6757-6762.
37. Narayanan P.K., Hart T., Elcock F., Zhang C., Hahn L., McFarland D., et al. Troglitazone-induced intracellular oxidative stress in rat hepatoma cells: a flow cytometric assessment. Cytometry 2003, 52A(1):28-35.
38. Hole P.S., Darley R.L., Tonks A. Do reactive oxygen species play a role in myeloid leukemias?. Blood 2011, 117(22):5816-5826.
39. Ito K., Hirao A., Arai F., Matsuoka S., Taukubo K., Hamaguchi I., et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004, 431(7011):997-1002.
40. McCord J.M., Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 1969, 224:6049-6055.
41. Kinnula V.L., Crapo J.D. Superoxide dismutases in malignant cells and human tumors. Free Radic Biol Med 2004, 36(6):718-744.